Clinical Genomics Lab Director – Hematologic Malignancies

BioNano Genomics; San Diego (CA); On-site; USD 260,000 - 340,000; Full time

Job summary

BioNano Genomics, through its Bionano Laboratories unit, seeks a Clinical Lab Director with board certification in LGG or ABMGG and CA director license to oversee hematologic genomic testing and sign-out for cytogenetic, CMA, CMA and NGS analyses using OGM.

The role requires deep expertise in myeloid/lymphoid neoplasms, QA/QC, proficiency testing, and collaboration with management to evaluate new technologies and ensure regulatory compliance under CLIA/CAP guidelines.

Qualifications

• Board certification or eligibility in LGG or ABMGG.
• M.D./Ph.D. or equivalent in pathology or related field.
• Clinical Laboratory Director license for high-complexity testing.
• Experience overseeing proficiency testing and QA/QC programs.
• Expert interpretation of structural variants and NGS data.
• Familiarity with CAP/CLIA/CDPH inspections and regulatory affairs.
• OGM experience preferred.

Responsibilities

• Oversee proficiency testing and quality reports.
• Design, review, and approve validation plans and reports.
• Sign-out of clinical diagnostic OGM data with clinical/phenotypic info.
• Update clinical tools and reference files for case comparisons.
• Contribute to publications, conferences, and education.
• Interpret complex genomic findings integrating multiple platforms.
• Engage with regulators and payer stakeholders.

Skills

Medical genetics expertise

Hematologic malignancies knowledge

Cytogenetics knowledge

NGS interpretation

Payer requirements knowledge

OGM knowledge

Regulatory & quality oversight

Communication skills

Education

M.D./Ph.D. or equivalent

LGG or ABMGG board certification

Clinical Laboratory Director license (CA)

Tools

Optical Genome Mapping (OGM)

Chromosomal microarray (CMA)

Next-generation sequencing (NGS) platforms

Job description

BioNano Genomics, through its Bionano Laboratories unit, seeks a Clinical Lab Director with board certification in LGG or ABMGG and CA director license to oversee hematologic genomic testing and sign-out for cytogenetic, CMA, CMA and NGS analyses using OGM.

The role requires deep expertise in myeloid/lymphoid neoplasms, QA/QC, proficiency testing, and collaboration with management to evaluate new technologies and ensure regulatory compliance under CLIA/CAP guidelines.